Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

Inovio's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Inovio is a pharmaceutical company that researches, develops and commercializes synthetic vaccines and immune therapies ... Read more

Based on data from Inovio's latest SEC filings

Annual Revenue

Based on data from Inovio's latest SEC filings

Employees

J. Joseph Kim's photo - President & CEO of Inovio

President & CEO

J. Joseph Kim

CEO Approval Rating

75/100

OVERVIEW

Founded:

1979

Headquarters:

Plymouth Meeting, Pennsylvania
Delaware Valley

Status:

PublicNASDAQINO

Industry Sector:

Biotechnology

SIC Code:

2836NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Advaxis a competitor of Inovio?

I don't know

Trending News for Inovio and Inovio's Competitors

June 4, 2020

Reuters

Inovio partners with non-profit organization to begin COVID-19 vaccine trial

Inovio Pharmaceuticals Inc on Thursday said it partnered with non-profit organization International V... See more »

June 3, 2020

Benzinga

ChemoCentryx Phase III ADVOCATE Trial of Avacopan in ANCA-Associated Vasculitis Highlighted in Oral Plenary Presentations at EULAR and ERA-EDTA Congresses

MOUNTAIN VIEW, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (NASDAQ:CCXI) today anno... See more »

June 3, 2020

FinanzNachrichten

AGEN, AGE To Battle Coronavirus, BCLI Awaits ALS Trial Data, FDA Delays Decision On NVS' Drug

BASEL (dpa-AFX) - Today's Daily Dose brings you news about Agenus' foray into COVID-19 drug developme... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

CytImmune is seen as one of Inovio's biggest rivals. CytImmune is headquartered in Rockville, Maryland, and was founded in 1996. Like Inovio, CytImmune also works within the Biotechnology sector. CytImmune generates 191% the revenue of Inovio.

bluebird bio is seen as one of Inovio's top competitors. bluebird bio was founded in 1992, and its headquarters is in Cambridge, Massachusetts. bluebird bio operates in the Biotechnology industry. bluebird bio has 809 more employees than Inovio.

Kite is one of Inovio's top rivals. Kite is a Private company that was founded in Santa Monica, California in 2009. Kite is in the Pharmaceuticals industry. Kite has 1,719 more employees vs. Inovio.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

J. Joseph Kim

President & CEO

- -
281
$296.4M
$2.6M
1

Saba Malak

Chairman & CEO

87/100
15
$8.6M
$5M
2

Nick Leschly

President & CEO

79/100
764
$275.9M
$44.7M
3

Christi L. Shaw

CEO

83/100
447
$225.2M
$32.1M
4

Ryan Spencer

CEO

88/100
249
$484.9M
$40.4M
5

Kenneth A. Berlin

President & CEO

81/100
35
$53.6M
$1.2M
6

Lothar Germeroth

Managing Director

81/100
663
$1.5B
$106M
7

Carlos Paya

President & CEO

88/100
50
$160.5M
$2.2M
8

Garo H. Armen

Chairman & CEO

90/100
294
$284.2M
$221.6M
9

Thomas J. Schall

Chairman & CEO

89/100
76
$289.5M
$33.8M
10

Armando Anido

Chairman & CEO

79/100
25
$55M
$ < 1M
The top 10 competitors in Inovio's competitive set are CytImmune, bluebird bio, Kite, Dynavax, Advaxis, Juno, Immune Design, Agenus, ChemoCentryx and Zynerba. Together they have raised over 3.3B between their estimated 4.5K employees. Inovio has 281 employees and is ranked 5th among it's top 10 competitors. The top 10 competitors average 263.

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$2.6M

Inovio's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 44.5M. Over the last four quarters, Inovio's revenue has grown by 878.3%. Specifically, in Q1 2020's revenue was $1.3M; in Q4 2019, it was $ < 1M; in Q3 2019, it was $ < 1M; in Q2 2019, Inovio's revenue was $ < 1M.

Acquisitions

No recent acquisitions found related to Inovio

Inovio Funding History

Since Inovio was founded in 1979, it has participated in 15 rounds of funding. In total Inovio has raised $296.4M. Inovio's last funding round was on Mar 2020 for a total of $5.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Grant
Mar 2020
$5M
Grant
Jan 2020
$9M
Debt
Dec 2019
$4M
-
Grant
Sep 2019
--
Private Placement
Jul 2019
$15.2M

Total Funding: $296.4M

Since Inovio was founded in 1979, it has participated in 15 rounds of funding. In total Inovio has raised $296.4M. Inovio's last funding round was on Mar 2020 for a total of $5.0M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Geneos is a pharmaceutical company that researches and develops immunotherapeutics for the treatment of cancer.
$10.5M
Feb 20, 2019
Series A
-

Inovio News

June 1, 2020PharmiWeb

INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models

PLYMOUTH MEETING, Pa., May 20, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO) today announced the publicati... See more »
May 28, 2020Seeking Alpha

How Inovio Pharmaceuticals Could Make It To 'The Show'

See more »
May 22, 2020Seeking Alpha

Coming Of Age In A Pandemic

See more »
May 21, 2020Equity Guru

Inovio Pharmaceuticals (INO.Q) preclinical trials show promise in the fight against COVID-19

Inovio Pharmaceuticals (INO.Q) announced the publication of the preclinical study data for its COVID-... See more »
May 20, 2020Reuters

UPDATE 2-Inovio says COVID-19 vaccine produces antibodies in mice, guinea pigs

U.S. immunotherapy company Inovio Pharmaceuticals Inc said on Wednesday its experimental vaccine to p... See more »
May 20, 2020FinanzNachrichten

What's The Buzz?

WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO), one of the key players in the race to devel... See more »
May 20, 2020Benzinga

Inovio Pharmaceuticals

read more... See more »

Inovio Press Releases

April 15, 2020centralcharts

INOVIO to Host its Annual Meeting of Stockholders in Virtual Format and at a New Time

INOVIO to Host its Annual Meeting of Stockholders in Virtual Format and at a New Time PR Newswire PLY... See more »
March 26, 2020centralcharts

Inovio Pharmaceuticals, Inc. - INO Stock Chart Technical Analysis for 03-26-2020

News videos - Inovio Pharmaceuticals, Inc. - INO Stock Chart Technical Analysis for 03-26-2020 - Publ... See more »
March 19, 2020NewsFile

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Inovio Pharmaceuticals, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - March 19, 2020) - Faruqi & Faruqi, LLP, a leading national secu... See more »
January 8, 2020StreetInsider

BLS Pharma Alleges Inovio's Breach of Contract Obstructed Ability to Deliver Testosterone Replacement Therapy for Hypogonadism and the Transgender Community

SANTA ANA, Calif.--(BUSINESS WIRE)-- BLS Pharma, Inc. filed a complaint late last month against Genet... See more »
November 5, 2019PR Newswire Asia

Inovio Demonstrates 80% 6-Month Progression-Free Survival In Phase 2 Glioblastoma Multiforme (GBM) Study with INO-5401 In Combination with PD-1 Inhibitor Libtayo® (cemiplimab)

80% of Methylated Patients and 75% of Unmethylated Patients Were Disease Progression-Free at 6 Months... See more »
July 16, 2019PR Newswire

Inovio Sharpens Focus On HPV-Related Diseases And Fast-to-Market Product Candidates

PLYMOUTH MEETING, Pa., July 16, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) annou... See more »
April 2, 2019PR Newswire Asia

Inovio Presents Cancer Killing Data of Its Transformative DNA-Encoded Bi-specific T Cell Engagers (dBiTEs) at AACR

Data demonstrates tumor-clearing ability of Inovio's dBiTE technology in preclinical cancer modelPLYM... See more »

Inovio Videos

January 26, 2017Inovio Youtube Channel

"Welcome to Inovio 2017" on YOUTUBE

See more »
September 2, 2015Inovio Youtube Channel

"Cancer Cell Destruction" on YOUTUBE

See more »
June 11, 2015Inovio Youtube Channel

"VGXI Congressional Visit" on YOUTUBE

See more »
May 21, 2014Inovio Youtube Channel

"Inovio Research Center Building Dedication" on YOUTUBE

See more »
February 25, 2014Inovio Youtube Channel

"Inovio scientific advisors & board member discuss DNA immunotherapy potential" on YOUTUBE

See more »

Social Statistics

Headquarters

660 West Germantown Pike Suite 110

Plymouth Meeting, Pennsylvania19462

1-267-440-4200

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Inovio is a pharmaceutical company that researches, develops and commercializes synthetic vaccines and immune therapies for the treatment of cancer. Inovio was founded in 1979. Inovio's headquarters is located in Plymouth Meeting, Pennsylvania, USA 19...

CEO

Inovio's President & CEO, J. Joseph Kim, currently has an approval rating of 75%. Inovio's primary competitors are CytImmune, bluebird bio & Kite.

Website

inovio.com

Frequently Asked Questions about Inovio

  1. When was Inovio founded?

    Inovio was founded in 1979

  2. Who is Inovio's CEO?

    Inovio's CEO is J. Joseph Kim

  3. How much revenue does Inovio generate?

    Inovio generates $2.6M in revenue

  4. How much funding does Inovio have?

    Inovio has historically raised $296.4M in funding

  5. Where is Inovio's headquarters?

    Inovio's headquarters is in Plymouth Meeting Pennsylvania, USA

  1. How many employees does Inovio have?

    Inovio has 281 employees

  2. What sector does Inovio operate in?

    Inovio is in Biotechnology

  3. Who are Inovio's competitors?

    Inovio's top competitors are CytImmune, bluebird bio, Kite

  4. Who has Inovio invested in?

    Inovio's has invested in companies such as Geneos Therapeutics
Stay up-to-date with the latest news on Inovio